1. Home
  2. VVOS vs PRTG Comparison

VVOS vs PRTG Comparison

Compare VVOS & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • PRTG
  • Stock Information
  • Founded
  • VVOS 2016
  • PRTG 1973
  • Country
  • VVOS United States
  • PRTG British Virgin Islands
  • Employees
  • VVOS 109
  • PRTG N/A
  • Industry
  • VVOS Medical Specialities
  • PRTG Oil & Gas Production
  • Sector
  • VVOS Health Care
  • PRTG Energy
  • Exchange
  • VVOS Nasdaq
  • PRTG Nasdaq
  • Market Cap
  • VVOS 17.5M
  • PRTG 17.7M
  • IPO Year
  • VVOS 2020
  • PRTG N/A
  • Fundamental
  • Price
  • VVOS $3.90
  • PRTG $5.66
  • Analyst Decision
  • VVOS Strong Buy
  • PRTG
  • Analyst Count
  • VVOS 2
  • PRTG 0
  • Target Price
  • VVOS $6.10
  • PRTG N/A
  • AVG Volume (30 Days)
  • VVOS 237.8K
  • PRTG 236.1K
  • Earning Date
  • VVOS 08-13-2025
  • PRTG 08-26-2025
  • Dividend Yield
  • VVOS N/A
  • PRTG N/A
  • EPS Growth
  • VVOS N/A
  • PRTG N/A
  • EPS
  • VVOS N/A
  • PRTG N/A
  • Revenue
  • VVOS $14,628,000.00
  • PRTG N/A
  • Revenue This Year
  • VVOS $17.40
  • PRTG N/A
  • Revenue Next Year
  • VVOS $10.78
  • PRTG N/A
  • P/E Ratio
  • VVOS N/A
  • PRTG N/A
  • Revenue Growth
  • VVOS 9.47
  • PRTG N/A
  • 52 Week Low
  • VVOS $1.97
  • PRTG $2.10
  • 52 Week High
  • VVOS $6.28
  • PRTG $23.01
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 73.57
  • PRTG 41.07
  • Support Level
  • VVOS $3.11
  • PRTG $5.32
  • Resistance Level
  • VVOS $3.91
  • PRTG $6.00
  • Average True Range (ATR)
  • VVOS 0.33
  • PRTG 0.67
  • MACD
  • VVOS 0.13
  • PRTG -0.01
  • Stochastic Oscillator
  • VVOS 60.38
  • PRTG 21.17

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About PRTG Portage Biotech Inc.

Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.

Share on Social Networks: